Top

BMC Cancer

Published in:

Open Access 01-12-2015 | Research article

No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study

Published in: BMC Cancer | Issue 1/2015

Title: No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study
Publication date: 01-12-2015
Published in: BMC Cancer / Issue 1/2015
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-015-1719-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2015

Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging

Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe

Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression

The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer